MetaRing quickly identifies breast cancer drug sensitivity

MetaRing quickly identifies breast cancer drug sensitivity

Recently, a research team led by Prof. Wang Hongzhi from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has developed a programmable plasmonic ring biosensor, MetaRing, capable of rapidly and accurately identifying paclitaxel sensitivity in breast cancer patients. The study is published in Biosensors and Bioelectronics.